Technical Briefs
Blood was sampled into Venoject plain red-top and SST tubes from 10 patients who were taking ammnoglycoside drugs. The samples were left upright, undisturbed, for 30 mm at room temperature to allow the samples to coagulate and then were centrifuged at 1500g for 10 mm. Serum from the Venoject plain red-top tubes was pipetted into polypropylene tubes immediately after centrifugation (reference tubes). The collection tubes were stored at 4 #{176}C with 1 mL and 0.2 mL of serum left in contact with gel barrier, and an aliquot of each sample was pipetted into polypropylene tubes after 1 and 2 days. We measured the serum drug concentrations in all of the samples in the same run, using Emit immunoassays (Syva, Palo Alto, CA) and a Cobas-Mira automated analyzer. The average CV of this method for assay of all ammnoglycosides was <4.2%. We observed significant time-and volume-dependent decreases in the measured concentrations of tobramicin and amikacin when the serum was stored at 0-4 #{176}C in Vacutainer aSamples collected in Venoject red-top tubes showed no decrease, and the CV was <3.2% in all cases, in drug concentrations during storage at 0-4 "C.
bResults shown are mean ISO) for 10 patients, with stored samples of 0.2 mL of serum: no significant differences were seen for stored volume of 1 mL.
cSignificantly different from reference value: P <0,05 lStudent's t-test).
SST tubes (Table 1 With this methodology in hand, we addressed the question of variability in plasma nonesterified arachidonate between fasting and nonfasting states in 11 healthy subjects. We now report that the concentration of free arachidonate in normal nonfasting plasma is 1.2 ± 0.3 jtmolfL (mean ± SD), with a range of normal values from 0.7 to 1.5 j.tmol/L [9]. This concentration is significantly lower than most of the values previously reported [1] [2] [3] [4] [5] [6] [7] [8] .
In the present investigation, our goal was to determine the fluctuation in the concentration of plasma nonesterified arachidonate in healthy individuals in nonfasting and fasting states. We found that, as nonesterified fatty acid concentrations in healthy individuals increased in the fasting state to exceed the values in the nonfasting state, the relative increase in arachidonate was the lowest among all the nonesterified fatty acids. Blood samples were collected into EDTA Vacutainer Tubes (Becton Dickinson, Rutherford, NJ) from 11 individuals in the fasting state (for 8 to 12 h) and subsequently in the nonfasting state. None was taking medications at the time of the study. Total plasma lipids were extracted by using a modified Foich method
[10],after which total nonesterified fatty acid was isolated by using thin-layer chromatography (TLC). Nonesterifled fatty acids isolated by TLC were methylated with methanol: acetyl chloride (50:1, by vol) and quantified by gas chromatography [7] .
The data in Table I are the results of nonesterified fatty acid analyses for the 11 individuals in the fasting and nonfasting states. As shown, the concentration of nonesterified arachidonate in the plasma of fasting individuals was 2.2 ± 0.6 tmol/L. The absolute amount of increase (in jmol/L) from the nonfasting to the fasting states was lowest for nonesterified arachidonate among all the fatty acids, in large part because the baseline concentration of nonesterified arachidonate in the plasma was the lowest of all the fatty acids detected (Table 1) . Notably, however, with fasting, arachidonate showed the lowest percent increase of all the nonesterified fatty acids. Stearate also showed a relatively small increase. The large standard deviations in the 
